2016
DOI: 10.1038/ijo.2016.101
|View full text |Cite
|
Sign up to set email alerts
|

A new era of addiction treatment amplifies the stigma of disease and treatment for individuals with obesity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 25 publications
0
1
0
Order By: Relevance
“…Furthermore, individuals with obesity prescribed certain antiobesity medications may also face the stigma against people with a history of drug use. In particular, the prescription of naltrexone—a therapeutic also used to treat individuals with opioid disorders—to patients with obesity may increase their stigma burden by subjecting them to the biases associated with substance-use disorders 4…”
mentioning
confidence: 99%
“…Furthermore, individuals with obesity prescribed certain antiobesity medications may also face the stigma against people with a history of drug use. In particular, the prescription of naltrexone—a therapeutic also used to treat individuals with opioid disorders—to patients with obesity may increase their stigma burden by subjecting them to the biases associated with substance-use disorders 4…”
mentioning
confidence: 99%